OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
How to approach shared decision making when determining consolidation, maintenance therapy, and transplantation in acute myeloid leukemia
Alison R. Walker
Hematology (2020) Vol. 2020, Iss. 1, pp. 51-56
Open Access | Times Cited: 10
Alison R. Walker
Hematology (2020) Vol. 2020, Iss. 1, pp. 51-56
Open Access | Times Cited: 10
Showing 10 citing articles:
Communication Strategies of Transplant Hematologists in High-Risk Decision-Making Conversations
Rachel Rodenbach, Thorunn Thordardottir, Markus Bräuer, et al.
JCO Oncology Practice (2024) Vol. 20, Iss. 4, pp. 538-548
Closed Access | Times Cited: 3
Rachel Rodenbach, Thorunn Thordardottir, Markus Bräuer, et al.
JCO Oncology Practice (2024) Vol. 20, Iss. 4, pp. 538-548
Closed Access | Times Cited: 3
Exosomes and Extracellular Vesicles in Myeloid Neoplasia: The Multiple and Complex Roles Played by These “Magic Bullets”
Simona Bernardi, Mirko Farina
Biology (2021) Vol. 10, Iss. 2, pp. 105-105
Open Access | Times Cited: 18
Simona Bernardi, Mirko Farina
Biology (2021) Vol. 10, Iss. 2, pp. 105-105
Open Access | Times Cited: 18
Acute myeloid leukaemia in patients we judge as being older and/or unfit
Vladimir Lazarević
Journal of Internal Medicine (2021) Vol. 290, Iss. 2, pp. 279-293
Closed Access | Times Cited: 13
Vladimir Lazarević
Journal of Internal Medicine (2021) Vol. 290, Iss. 2, pp. 279-293
Closed Access | Times Cited: 13
Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection
Simona Bernardi, Mirko Farina, Katia Bosio, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4504-4504
Open Access | Times Cited: 9
Simona Bernardi, Mirko Farina, Katia Bosio, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4504-4504
Open Access | Times Cited: 9
Novel therapies vs hematopoietic cell transplantation in myelofibrosis: who, when, how?
James T. England, Vikas Gupta
Hematology (2021) Vol. 2021, Iss. 1, pp. 453-462
Open Access | Times Cited: 11
James T. England, Vikas Gupta
Hematology (2021) Vol. 2021, Iss. 1, pp. 453-462
Open Access | Times Cited: 11
High-dose cytarabine monotherapy is superior to standard-dose cytarabine- based multiagent sequential treatment cycle for consolidation treatment in adult (14-59 years) AML patients according to European Leukemia Net 2022 risk stratification
Xiaoyu Wang, Dan Liu, Erling Chen, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 4
Xiaoyu Wang, Dan Liu, Erling Chen, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 4
Comparison of clinical outcomes between transplant and nontransplant therapies in myelofibrosis following failure of first‐line JAK‐inhibitor
James T. England, Eshetu G. Atenafu, James A. Kennedy, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 5
Open Access | Times Cited: 4
James T. England, Eshetu G. Atenafu, James A. Kennedy, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 5
Open Access | Times Cited: 4
Medium-cumulative dose of cytarabine in consolidation therapy shows the greatest benefit in AML patients
Yiping Hao, Min Ji, Shumin Jin, et al.
Holistic Integrative Oncology (2024) Vol. 3, Iss. 1
Open Access
Yiping Hao, Min Ji, Shumin Jin, et al.
Holistic Integrative Oncology (2024) Vol. 3, Iss. 1
Open Access
Treating acute myeloid leukaemia in patients over 60 years of age in the era of targeted therapy
Miloslava Hisemová, Zdeněk Ráčil
Onkologie (2022) Vol. 16, Iss. 1, pp. 25-32
Closed Access
Miloslava Hisemová, Zdeněk Ráčil
Onkologie (2022) Vol. 16, Iss. 1, pp. 25-32
Closed Access
Moving the Treatment of Acute Myeloid Leukemia to the Outpatient Setting: Current Expert Perspectives and Consensus Findings
Chetasi Talati, Kendra Sweet, Daniel A. Pollyea, et al.
Journal of Clinical Haematology (2021) Vol. 2, Iss. 3
Open Access
Chetasi Talati, Kendra Sweet, Daniel A. Pollyea, et al.
Journal of Clinical Haematology (2021) Vol. 2, Iss. 3
Open Access
